Anti-aging composition containing stem cell exosome, preparation method of anti-aging composition and application of anti-aging composition in cosmetics

By combining stem cell exosomes with palmitoyl tetrapeptide-7 and astaxanthin, and using surfactants and protective agents, the problem of poor stability of anti-aging components is solved, significantly improving the anti-aging effect and enhancing bioavailability and stability, and play a role in anti-aging.

CN118902970AInactive Publication Date: 2024-11-08SHENZHEN XINSAIER BIOTECHNOLOGY CO LTD

Patent Information

Application Number
CN202410996957.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The poor stability of existing anti-aging ingredients such as exosomes, natural antioxidants and peptides leads to low bioavailability in anti-aging and poor anti-aging effects.

Method used

Stem cell exosomes are combined with palmitoyl tetrapeptide-7 and astaxanthin, and the stability and bioavailability of the active ingredients are enhanced through the synergistic action of the surfactant and the protective agent to prepare an anti-aging composition.

Benefits of technology

It significantly improved the loading rate and drug loading rate of palmitoyl tetrapeptide-7 and astaxanthin, enhanced the stability of stem cell exosomes, synergistically exerted anti-aging effects, reduced melanoma cell viability and tyrosinase activity, and improved D-galactose-induced hydroxyproline and hyaluronic acid content in rat aging models and inhibited the increase of MDA.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004960571750000081
    Figure BDA0004960571750000081
  • Figure BDA0004960571750000091
    Figure BDA0004960571750000091
  • Figure BDA0004960571750000092
    Figure BDA0004960571750000092
Patent Text Reader

Abstract

The invention provides an anti-aging composition containing stem cell exosomes, a preparation method of the anti-aging composition and application of the anti-aging composition in cosmetics, and belongs to the technical field of biology. The anti-aging composition containing the stem cell exosome is prepared from the stem cell exosome, palmitoyl tetrapeptide-7, astaxanthin, a surfactant and a protective agent. According to the preparation method disclosed by the invention, the palmitoyl tetrapeptide-7 and the astaxanthin are wrapped by the stem cell exosome in an incubation process, and then the stem cell exosome wrapping the palmitoyl tetrapeptide-7 and the astaxanthin is wrapped by the protective agent, so that the stability and the bioavailability of the palmitoyl tetrapeptide-7, the astaxanthin and the stem cell exosome are enhanced. According to the preparation method disclosed by the invention, the leakage of active ingredients in the stem cell exosome is effectively prevented, the entrapment rate and the drug loading rate of the palmitoyl tetrapeptide-7 and the astaxanthin are improved, the advantages of the stem cell exosome, the palmitoyl tetrapeptide-7 and the astaxanthin are fully played, and a positive effect is achieved in the aspect of anti-aging.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, and in particular to an anti-aging composition containing stem cell exosomes, a preparation method thereof, and an application thereof in cosmetics. Background Art

[0002] Aging refers to the irreversible natural phenomenon that occurs after a biological organism matures. Under normal circumstances, the body's functions decline, the ability to stabilize the internal environment decreases, the structural components gradually degenerate, and the body tends to die as it ages. How to scientifically fight aging and delay the occurrence and development of aging-related diseases has become a hot topic of concern for many people.

[0003] Exosomes refer to small membrane vesicles (30-150nm) containing complex RNA and proteins. Nowadays, they specifically refer to discoid vesicles with a diameter of 40-100nm. Exosomes contain rich substances, such as cytokines, growth factors, lipids, mRNAs and regulatory miRNAs, which are mainly involved in cell-to-cell communication and change the microenvironment of tissues. They play an invaluable role in regulating target cell communication, immune response, cell regeneration and differentiation. Natural antioxidants can reduce the oxidative attack of intracellular biomacromolecules (such as DNA, proteins, and lipids), thereby protecting the structural and functional integrity of cells. Peptides are important physiological regulators of the human body. They can comprehensively regulate the physiological functions of the human body, stimulate the regeneration of cells and collagen, and effectively fight aging. Therefore, exosomes, natural antioxidants, peptides, etc. are often used as anti-aging ingredients. However, the above ingredients have poor stability, which reduces their bioavailability in anti-aging, resulting in poor anti-aging effects. Summary of the invention

[0004] The purpose of the present invention is to provide an anti-aging composition containing stem cell exosomes, a preparation method thereof and an application thereof in cosmetics. The present invention combines exosomes, palmitoyl tetrapeptide-7 and astaxanthin, which has a synergistic effect in anti-aging. The preparation method of the present invention can enhance the stability of the active ingredients, improve the bioavailability, and enhance the anti-aging effect of the composition.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The present invention provides a method for preparing an anti-aging composition containing stem cell exosomes, comprising: preparing a solution of palmitoyl tetrapeptide-7 and astaxanthin, and mixing the solution with a surfactant to obtain a mixed solution; mixing the stem cell exosomes with the mixed solution, incubating the solution, mixing and stirring the solution with a protective agent, and filtering the solution with a sterile filter membrane to obtain the anti-aging composition.

[0007] Preferably, the stem cell exosomes are bovine umbilical cord mesenchymal stem cell exosomes, the surfactant is Tween 80 or Poloxamer 101; and the protective agent is trehalose or chitosan.

[0008] Preferably, the method for preparing bovine umbilical cord mesenchymal stem cell exosomes comprises: culturing bovine umbilical cord mesenchymal stem cells under hypoxic conditions, collecting the supernatant, and separating by differential ultracentrifugation to obtain stem cell exosomes.

[0009] More preferably, the culture conditions are 35-40°C, 25-35rpm, 3%-8% CO2, 3%-7% O2.

[0010] Preferably, the differential centrifugation comprises: centrifuging the supernatant at 200-500g for 8-6min; at 1800-2200g for 25-35min; at 11000-13000g for 25-35min; after filtration, centrifuging the filtrate at 110000-130000g for 3-5h and discarding the supernatant.

[0011] Preferably, the incubation temperature is 35-40°C, the rotation speed is 75-85 rpm, and the time is 10-14 hours.

[0012] Preferably, the concentration of palmitoyl tetrapeptide-7 in the mixed solution is 2-4 mg / mL, the concentration of astaxanthin is 2-4 mg / mL; the concentration of stem cell exosomes is 450-550 μg / mL; and the volume ratio of the mixed solution to the stem cell exosomes is 1-3:1-3.

[0013] Preferably, the pore size of the sterile filter membrane is 0.2-0.45 μm.

[0014] The present invention also provides an anti-aging composition containing stem cell exosomes obtained by the above preparation method.

[0015] The present invention also provides application of the anti-aging composition in preparing anti-aging cosmetics.

[0016] Compared with the prior art, the present invention has the following beneficial effects:

[0017] The present invention provides an anti-aging composition containing stem cell exosomes, including: stem cell exosomes, palmitoyl tetrapeptide-7, astaxanthin, a surfactant and a protective agent. The present invention encapsulates palmitoyl tetrapeptide-7 and astaxanthin with stem cell exosomes through an incubation process, and then encapsulates the stem cell exosomes encapsulating palmitoyl tetrapeptide-7 and astaxanthin with a protective agent, thereby enhancing the stability and bioavailability of palmitoyl tetrapeptide-7, astaxanthin and stem cell exosomes. The preparation method of the present invention effectively prevents the leakage of active ingredients in stem cell exosomes, improves the encapsulation rate and drug loading rate of palmitoyl tetrapeptide-7 and astaxanthin, and gives full play to the advantages of stem cell exosomes, palmitoyl tetrapeptide-7 and astaxanthin. Stem cell exosomes have the characteristic of being easy to penetrate cell membranes. After encapsulating palmitoyl tetrapeptide-7 and astaxanthin, it is beneficial for palmitoyl tetrapeptide-7 and astaxanthin to enter cells to play a role, and has a synergistic effect in anti-aging.

[0018] The experimental results show that the surfactant and protective agent added in the present invention can significantly increase the loading rate of palmitoyl tetrapeptide-7 and astaxanthin; the anti-aging composition of the present invention can significantly reduce the viability of melanoma cells and the activity of tyrosinase, and reduce the melanin content; the anti-aging composition of the present invention can significantly increase the content of hydroxyproline and hyaluronic acid in the D-galactose-induced rat aging model, and increase the activity of SOD and GSH-Px in plasma, and inhibit the increase of MDA, and has excellent anti-aging effect. DETAILED DESCRIPTION

[0019] The present invention provides a method for preparing an anti-aging composition containing stem cell exosomes, comprising: preparing a solution of palmitoyl tetrapeptide-7 and astaxanthin, and mixing the solution with a surfactant to obtain a mixed solution; mixing the stem cell exosomes with the mixed solution, incubating the solution, mixing and stirring the solution with a protective agent, and filtering the solution with a sterile filter membrane to obtain the anti-aging composition.

[0020] The stem cell exosomes of the present invention are preferably bovine umbilical cord mesenchymal stem cell exosomes, the surfactant is preferably Tween 80 or poloxamer 101; and the protective agent is preferably trehalose or chitosan.

[0021] The method for preparing stem cell exosomes of the present invention preferably comprises: culturing bovine umbilical cord mesenchymal stem cells under hypoxic conditions, collecting the supernatant, and separating by differential ultracentrifugation to obtain stem cell exosomes; the culture conditions are preferably 35-40°C, 25-35rpm, 3%-8% CO2, 3%-7% O2, and more preferably 37°C, 30rpm, 5% CO2, 5% O2.

[0022] The differential centrifugation of the present invention preferably includes: centrifuging the supernatant at 200-500g for 8-6min; centrifuging at 1800-2200g for 25-35min; centrifuging at 11000-13000g for 25-35min; after filtration, centrifuging the filtrate at 110000-130000g for 3-5h and discarding the supernatant. More preferably, the method includes: centrifuging the supernatant at 300g for 10 minutes, aspirating the supernatant, and removing dead cells; centrifuging at 2000g for 30 minutes, aspirating the supernatant, and removing cell debris; centrifuging at 12000g for 30 minutes, aspirating the supernatant, and removing apoptotic bodies; filtering the culture medium supernatant with 0.22μm to remove extracellular vesicles larger than 200nm; centrifuging at 120000g for 4h, discarding the supernatant, and resuspending the precipitate with physiological saline to obtain bovine umbilical cord mesenchymal stem cell exosomes with a concentration of 500μg / mL, and the temperature of the differential centrifugation is preferably 4°C.

[0023] The incubation temperature of the present invention is preferably 35-40°C, more preferably 37°C, the rotation speed is preferably 75-85rpm, more preferably 80rpm, and the time is preferably 10-14h, more preferably 12h.

[0024] The stirring speed of the present invention is preferably 250-350 rpm, more preferably 300 rpm, and the time is preferably 10-14 h, more preferably 12 h.

[0025] The concentration of palmitoyl tetrapeptide-7 in the mixed solution of the present invention is preferably 2-4 mg / mL, more preferably 3 mg / mL, the concentration of astaxanthin is preferably 2-4 mg / mL, more preferably 3 mg / mL; the concentration of the stem cell exosomes is preferably 450-550 μg / mL, more preferably 500 μg / mL; the volume ratio of the mixed solution and the stem cell exosomes is preferably 1-3:1-3, more preferably 2:2.

[0026] The pore size of the sterile filter membrane of the present invention is 0.2-0.45 μm, and the filtration is sterilized.

[0027] After filtration and sterilization, the present invention also preferably includes centrifuging the filtrate at 80,000 rpm for 30 minutes, discarding the supernatant (to remove unloaded palmitoyl tetrapeptide-7 and astaxanthin), and precipitating the anti-aging composition.

[0028] The present invention also provides an anti-aging composition containing stem cell exosomes obtained by the above preparation method.

[0029] In the incubation process of the present invention, palmitoyl tetrapeptide-7 and astaxanthin are encapsulated by stem cell exosomes, thereby improving the encapsulation rate and drug loading rate of palmitoyl tetrapeptide-7 and astaxanthin, and then the protective agent is used to encapsulate the exosomes encapsulating the active ingredients. The preparation method of the present invention will not destroy the integrity of the stem cell exosome membrane, can well maintain the content and activity of the original content, effectively prevent the leakage of active ingredients in the stem cell exosomes, and improve the stability of the anti-aging composition.

[0030] The stem cell exosomes of the present invention contain many cell cycle-related proteins that can inhibit the progression of the cell cycle, regulate the extracellular environment, promote the antioxidant and anti-inflammatory response of cells, and thus delay the aging process. In addition, the stem cell exosomes have the characteristic of being easy to penetrate the cell membrane. After wrapping palmitoyl tetrapeptide-7 and astaxanthin, it is beneficial for palmitoyl tetrapeptide-7 and astaxanthin to enter the cell and play a role. The stem cell exosomes, palmitoyl tetrapeptide-7 and astaxanthin of the present invention have a synergistic effect in anti-aging.

[0031] The present invention also provides application of the anti-aging composition in preparing anti-aging cosmetics.

[0032] In the present invention, unless otherwise specified, all raw material components are commercially available products well known to those skilled in the art.

[0033] The technical solutions in the present invention will be described clearly and completely below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0034] Example 1

[0035] Preparation of exosomes from bovine umbilical cord mesenchymal stem cells

[0036] (1) Preparation of bovine umbilical cord mesenchymal stem cells

[0037] Obtain the fetal bovine umbilical cord, wash the umbilical cord to remove residual blood, remove the umbilical artery, rinse with PBS (with 5% penicillin-streptomycin) solution, cut into small pieces, add mesenchymal stem cell culture medium (umbilical cord mesenchymal stem cell serum-free culture medium, product number NC0103+NC0103.S, Hangzhou Noyang Biotechnology Co., Ltd.), and culture in a CO2 incubator;

[0038] The mesenchymal stem cell culture medium was replaced every 3 days. After culturing for 8 days, the confluence reached about 80%, and the cells were rinsed once with PBS. Trypsin (mass fraction 0.25%)-EDTA was added for digestion until most cells became round and floated. The digestion was terminated to obtain a cell suspension.

[0039] The cell suspension was centrifuged at 300 g for 5 min, the supernatant was discarded, the cells were resuspended in culture medium, and 8,000-10,000 cells / cm2 were inoculated into a new MSC culture dish, an appropriate amount of culture medium was added, and the dish was placed in a CO2 incubator at 37° C. and 5% CO2 to obtain first-generation cells. According to the above operation steps, the bovine umbilical cord mesenchymal stem cells were amplified to obtain the third-generation bovine umbilical cord mesenchymal stem cells;

[0040] (2) Cultivation of bovine umbilical cord mesenchymal stem cells

[0041] The third generation bovine umbilical cord mesenchymal stem cells were digested and 5×10 6 Cells were counted at 500 / cm 2 Density and Cytodex TM The microcarriers were mixed, suspended in 50 mL of MSC culture medium (containing 1 g of microcarriers), mixed, and cultured at 5 min / h (5 minutes per hour), 30 rpm, 37°C, and 5% CO2 until the logarithmic growth phase. The culture medium was replaced and cultured for 96 h, and the culture supernatant was collected;

[0042] (3) Isolation of exosomes from bovine umbilical cord mesenchymal stem cells

[0043] The culture medium supernatant was centrifuged at 300g for 10 minutes, and the supernatant was aspirated; at 2000g, the supernatant was aspirated for 30 minutes, and the supernatant was aspirated; at 12000g, the supernatant was aspirated for 30 minutes; the culture medium supernatant was filtered through 0.22μm to remove extracellular vesicles larger than 200nm; at 120000g, the supernatant was discarded, and the precipitate was resuspended with physiological saline to obtain bovine umbilical cord mesenchymal stem cell exosomes with a concentration of 500μg / mL (the concentration is the ratio of the precipitate mass to the volume of physiological saline). All steps were carried out at 4°C.

[0044] Example 2

[0045] Preparation of anti-aging composition containing stem cell exosomes

[0046] (1) 0.05 g of palmitoyl tetrapeptide-7 and 0.05 g of astaxanthin were mixed and dissolved with 2 mL of anhydrous ethanol, and then mixed with 15 mL of 0.5% (W / V) Tween 80 aqueous solution to obtain a mixed solution;

[0047] (2) 5 mL of the bovine umbilical cord mesenchymal stem cell exosomes obtained in Example 1 was mixed with 5 mL of the mixed solution of step (1), and incubated at a temperature of 37° C. and a rotation speed of 80 rpm for 12 h to obtain stem cell exosomes loaded with palmitoyl tetrapeptide-7 and astaxanthin;

[0048] (3) 2 mL of stem cell exosomes loaded with palmitoyl tetrapeptide-7 and astaxanthin were mixed with 2 mL of 2% (W / V) chitosan aqueous solution, stirred at 300 rpm for 12 h, filtered and sterilized with a 0.25 μm sterile filter membrane, and the filtrate was centrifuged at 80,000 rpm for 30 min, the supernatant was discarded, and the anti-aging composition was precipitated.

[0049] Example 3

[0050] The specific implementation is the same as that of Example 2, except that Tween 80 is replaced by Poloxamer 101.

[0051] Example 4

[0052] The specific implementation is the same as that of Example 2, except that chitosan is replaced by trehalose.

[0053] Comparative Example 1

[0054] The specific implementation is the same as that of Example 2, except that the surfactant Tween 80 is not added.

[0055] Comparative Example 2

[0056] The specific implementation is the same as that of Example 2, except that the protective agent chitosan is not added.

[0057] Comparative Example 3

[0058] The specific implementation is the same as that of Example 2, except that palmitoyl tetrapeptide-7 is not added.

[0059] Comparative Example 4

[0060] The specific implementation is the same as that of Example 2, except that astaxanthin is not added.

[0061] Comparative Example 5

[0062] The specific implementation is the same as that of Example 2, except that palmitoyl tetrapeptide-7 and astaxanthin are not added.

[0063] Comparative Example 6

[0064] The specific implementation is the same as that of Example 2, except that the bovine umbilical cord mesenchymal stem cell exosomes are replaced with an equal amount of deionized water.

[0065] Experimental Example 1

[0066] Load rate detection

[0067] The loading rates of palmitoyl tetrapeptide-7 and astaxanthin in the anti-aging compositions obtained in Examples 2-4 and Comparative Examples 1-2 were respectively tested, and the specific results are shown in Table 1.

[0068] The samples were resuspended in acetone to destroy the structure of the exosomes, centrifuged at 1000 g for 15 min, the supernatant was collected, concentrated and dried on a rotary evaporator, and re-dissolved in methanol. The contents of palmitoyl tetrapeptide-7 and astaxanthin were detected by HPLC.

[0069] Loading rate (%) = detected active ingredient content / initial active ingredient content × 100%.

[0070] Table 1 Loading rates of palmitoyl tetrapeptide-7 and astaxanthin in different anti-aging compositions

[0071]

[0072]

[0073] It can be seen from the data in Table 1 that adding the surfactant and protective agent of the present invention in the preparation method can significantly increase the loading rate of palmitoyl tetrapeptide-7 and astaxanthin, and improve the stability and bioavailability of the anti-aging composition.

[0074] Experimental Example 2

[0075] Cell experiments

[0076] Mouse melanoma B16 was cultured to the logarithmic phase, washed with PBS, added with 1.5 mL of 0.25% trypsin and placed in an incubator for digestion for 1 min, aspirated out the trypsin and added with 3 mL of culture medium and gently pipetted to prepare a cell suspension. An appropriate amount of cells was inoculated into a cell plate and placed in an incubator for culture (37°C, 5% CO2 saturated humidity environment).

[0077] The density of mouse melanoma B16 cells was adjusted to 2.0 × 10 per ml. 5 , inoculated in a 96-well plate and cultured for 12 hours. The anti-aging compositions of Examples 2-4 and Comparative Examples 1-6 were added to the culture medium at a final concentration of 10 mg / L, and added to the mouse melanoma B16 adherent cells that had been cultured for 12 hours, 100 μL per well, and an equal volume of culture medium was set as a control group, with 6 replicates in each group. After incubation for 48 hours, the tyrosinase activity, cell proliferation activity and intracellular melanin content of each group were measured, and the specific results are shown in Table 2.

[0078] Among them, tyrosinase activity was determined using a tyrosinase inhibitor kit; cell proliferation activity was measured using a CCK8 kit; and melanin content was determined using a melanin staining kit.

[0079] Table 2 Effects of different anti-aging compositions on tyrosinase activity, cell proliferation activity and intracellular melanin content

[0080]

[0081]

[0082] From the data in Table 2, it can be seen that compared with Comparative Examples 1-2, the viability, tyrosinase activity and melanin content of melanoma cells in Example 2 group decreased more significantly, because the preparation method of the present invention can significantly increase the loading rate of palmitoyl tetrapeptide-7 and astaxanthin, thereby increasing the bioavailability of the effective ingredients. Compared with Comparative Examples 3-6, the viability, tyrosinase activity and melanin content of melanoma cells in Example 2 group decreased more significantly, indicating that the stem cell exosomes, palmitoyl tetrapeptide-7 and astaxanthin of the present invention have a synergistic effect, which can inhibit the increase of melanin caused by the aging process.

[0083] Experimental Example 3

[0084] Animal experiments

[0085] Sixty SPF Wistar rats, half male and half female, weighing 200-250 g, were fed adaptively for 7 days and randomly divided into three groups, each with 20 rats, half male and half female.

[0086] Control group: subcutaneous injection of 100 mg / kg / day of normal saline and oral administration of 10 mL / kg of distilled water every day for 7 consecutive weeks;

[0087] Model group: 5% D-galactose 100 mg / kg was injected subcutaneously at the back of the neck once a day for 7 consecutive weeks, and distilled water 10 mL / kg was given by gavage every day; after 7 weeks, the rats in this group had obvious coarse hair and slow movement, indicating that the model was successfully established;

[0088] Experimental group: 5% D-galactose 100 mg / kg was subcutaneously injected at the back of the neck once a day, and the anti-aging composition of Example 2 of the present invention was intragastrically administered at 10 g / kg every day for 7 consecutive weeks.

[0089] After the last administration, the rats were deprived of water and food for 12 h, plasma was collected, and after being sacrificed, back skin of the same size was obtained.

[0090] (1) Determination of hydroxyproline and hyaluronic acid content in skin

[0091] The contents of hydroxyproline and hyaluronic acid in the skin tissue of rats in each group were detected. The specific results are shown in Table 3.

[0092] The back skin of rats in each group was cut into pieces, ground with physiological saline, and then hydrolyzed with acid. The hydroxyproline content in the skin was measured using a spectrophotometer.

[0093] The back skin of rats in each group was cut into pieces, ground with physiological saline, and then the hyaluronic acid content was determined by enzyme-linked immunosorbent assay.

[0094] Table 3 Effects of different anti-aging compositions on the content of hydroxyproline and hyaluronic acid in the skin

[0095] Group Hydroxyproline (μg / mg) Hyaluronic acid (ng / L) Control group 45.8 3.9 Model Group 22.1 2.4 Experimental Group 39.4 3.2

[0096] It can be seen from the data in Table 3 that the anti-aging composition of Example 2 of the present invention can significantly increase the contents of hydroxyproline and hyaluronic acid in the D-galactose-induced rat aging model, and has an excellent anti-aging effect.

[0097] (2) Determination of SOD, GSH-Px and MDA levels in plasma

[0098] The levels of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and malondialdehyde (MDA) in the plasma of rats in each group were detected by kits, and the specific results are shown in Table 4.

[0099] Table 4 Effects of different anti-aging compositions on the levels of SOD, GSH-Px and MDA in plasma

[0100] Group SOD(pg / mL) GSH-Px (pg / mL) MDA (pg / mL) Control group 250.6 232.8 0.57 Model Group 120.7 115.1 1.64 Experimental Group 242.1 227.3 0.62

[0101] From the results in Table 4, it can be seen that the anti-aging composition of Example 2 of the present invention can significantly increase the activity of SOD and GSH-Px in the plasma of aging rats induced by D-galactose, and inhibit the increase of MDA, which indicates that the anti-aging composition of the present invention has an anti-aging effect.

[0102] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. A method for preparing an anti-aging composition containing stem cell exosomes, characterized in that: include: After preparing a solution of palmitoyl tetrapeptide-7 and astaxanthin, the solution is mixed with a surfactant to obtain a mixed solution; After the stem cell exosomes are mixed with the mixed solution and incubated, they are mixed with a protective agent and stirred, and filtered with a sterile filter membrane to obtain the anti-aging composition.

2. The preparation method according to claim 1, characterized in that: The stem cell exosomes are bovine umbilical cord mesenchymal stem cell exosomes, the surfactant is Tween 80 or Poloxamer 101; and the protective agent is trehalose or chitosan.

3. The preparation method according to claim 2, characterized in that: The method for preparing bovine umbilical cord mesenchymal stem cell exosomes comprises: culturing bovine umbilical cord mesenchymal stem cells under hypoxic conditions, collecting supernatant, and separating by differential ultracentrifugation to obtain stem cell exosomes.

4. The preparation method according to claim 3, characterized in that: The culture conditions are 35-40°C, 25-35rpm, 3%-8% CO2, 3%-7% O2.

5. The preparation method according to claim 3, characterized in that: The differential centrifugation comprises: centrifuging the supernatant at 200-500g for 8-6min; centrifuging at 1800-2200g for 25-35min; centrifuging at 11000-13000g for 25-35min; after filtering, centrifuging the filtrate at 110000-130000g for 3-5h and discarding the supernatant.

6. The preparation method according to claim 1, characterized in that: The incubation temperature is 35-40° C., the rotation speed is 75-85 rpm, and the time is 10-14 h.

7. The preparation method according to claim 1, characterized in that: The concentration of palmitoyl tetrapeptide-7 in the mixed solution is 2-4 mg / mL, the concentration of astaxanthin is 2-4 mg / mL; the concentration of the stem cell exosomes is 450-550 μg / mL; and the volume ratio of the mixed solution to the stem cell exosomes is 1-3:1-3.

8. The preparation method according to claim 1, characterized in that: The pore size of the sterile filter membrane is 0.2-0.45 μm.

9. An anti-aging composition containing stem cell exosomes obtained by the preparation method according to any one of claims 1 to 8.

10. Use of the anti-aging composition according to claim 9 in the preparation of anti-aging cosmetics.

Citation Information

Patent Citations

  • Lipstick containing stem cell secreting factor and preparation method of same

    CN107961174A

  • Stem cell exosome capable of repairing skin as well as preparation method and application thereof

    CN108837142A

  • Preparation method and application of exosome freeze-dried powder

    CN110897993A

  • Umbilical cord mesenchymal stem cell exosome and whitening application thereof

    CN112175910A

  • Stem cell exosome microneedle patch for removing freckles and wrinkles and preparation method of stem cell exosome microneedle patch

    CN112336749A

Cited By

  • Culture method and application of anti-aging stem cell exosome

    CN120137892A

  • A culture method and application of stem cell exosomes for anti-aging

    CN120137892B